Medicinova Inc Share Price Today: Live Updates & Key Insights

Medicinova Inc share price today is $1.5, up 12.23%. The stock opened at $1.39 against the previous close of $1.39, with an intraday high of $1.54 and low of $1.385.

Medicinova Inc Share Price Chart

Medicinova Inc

us-stock
To Invest in {{usstockname}}
us-stock

Medicinova Inc Share Price Performance

$1.5 0.1223(12.23%) MNOV at 23 Mar 2026 02:18 PM Biotechnology
Lowest Today 1.385
Highest Today 1.54
Today’s Open 1.39
Prev. Close 1.39
52 Week High 1.96
52 Week Low 1.13
Day’s Range: Low 1.385 High 1.54
52-Week Range: Low 1.13 High 1.96
1 day return -
1 Week return +5.51
1 month return +3.37
3 month return +9.28
6 month return +20.47
1 year return +5.51
3 year return -27.14
5 year return -72.82
10 year return -

Medicinova Inc Institutional Holdings

Essex Woodlands Health Ventures 2.25

Vanguard Group Inc 1.43

BlackRock Inc 1.42

Citigroup Inc 1.21

Geode Capital Management, LLC 1.08

Vanguard Institutional Extnd Mkt Idx Tr 0.96

Fidelity Extended Market Index 0.52

UBS Group AG 0.45

Renaissance Technologies Corp 0.40

State Street Corp 0.35

Jane Street Group LLC 0.33

Northern Trust Corp 0.27

iShares Micro-Cap ETF 0.25

Bank of New York Mellon Corp 0.20

Blackrock Extended Mkt Fund CF 0.19

Bank of America Corp 0.19

Barclays PLC 0.18

Fidelity Total Market Index 0.18

Extended Equity Market Fund K 0.17

Bridgeway Capital Management, LLC 0.15

Charles Schwab Investment Management Inc 0.15

Schwab Total Stock Market Index 0.15

Bridgeway Ultra-Small Company Market 0.14

Fidelity Series Total Market Index 0.13

Dimensional Fund Advisors, Inc. 0.13

Spartan Extended Market Index Pool F 0.12

SBI Securities Co Ltd 0.09

Northern Trust Extended Eq Market Idx 0.09

NT Ext Equity Mkt Idx Fd - L 0.09

Two Sigma Investments LLC 0.08

NT Ext Equity Mkt Idx Fd - NL 0.07

Spartan Total Market Index Pool G 0.07

Schonfeld Strategic Advisors LLC 0.07

Lantern Wealth Advisors LLC 0.06

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.06

Fidelity Nasdaq Composite Index 0.05

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.03

Vanguard U.S. Eq Idx £ Acc 0.03

Northern Small Cap Core I 0.03

Dimensional Global Core Equity USD Acc 0.02

Medicinova Inc Market Status

Strong Buy: 2

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Medicinova Inc Fundamentals

Market Cap 76.79 M

PB Ratio 1.8227

PE Ratio 0.0

Enterprise Value 45.19 M

Total Assets 45.60 M

Volume 400468

Medicinova Inc Company Financials

Annual Revenue FY25:409657 0.4M, FY24:0 0.0M, FY23:1000000 1.0M, FY22:0 0.0M, FY21:4037500 4.0M

Annual Profit FY25:31051 0.0M, FY24:null 0.0M, FY23:null 0.0M, FY22:null 0.0M, FY21:4037500 4.0M

Annual Net worth FY25:-11997957 -12.0M, FY24:-11049549 -11.0M, FY23:-9513915 -9.5M, FY22:-14069083 -14.1M, FY21:-10134252 -10.1M

Quarterly Revenue Q4/2025:151739 0.2M, Q3/2025:123319 0.1M, Q2/2025:134599 0.1M, Q1/2025:0 0.0M, Q4/2024:0 0.0M

Quarterly Profit Q4/2025:51758 0.1M, Q3/2025:-38957 -0.0M, Q2/2025:18250 0.0M, Q1/2025:-5177 -0.0M, Q4/2024:null 0.0M

Quarterly Net worth Q4/2025:-2802279 -2.8M, Q3/2025:-3050373 -3.1M, Q2/2025:-3281185 -3.3M, Q1/2025:-2864120 -2.9M, Q4/2024:-2814652 -2.8M

About Medicinova Inc & investment objective

Company Information MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.

Organisation Biotechnology

Employees 6

Industry Biotechnology

CEO Dr. Yuichi Iwaki M.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Medicinova Inc FAQs

What is the share price of Medicinova Inc today?

The current share price of Medicinova Inc is $1.5.

Can I buy Medicinova Inc shares in India?

Yes, Indian investors can buy Medicinova Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Medicinova Inc shares in India?

You can easily invest in Medicinova Inc shares from India by:

Can I buy fractional shares of Medicinova Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Medicinova Inc?

Medicinova Inc has a market cap of $76.79 M.

In which sector does Medicinova Inc belong?

Medicinova Inc operates in the Biotechnology sector.

What documents are required to invest in Medicinova Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Medicinova Inc?

The PE ratio of Medicinova Inc is N/A and the PB ratio is 1.82.